High DKK1 expression in GC correlates with tumor progression, poor prognosis, and an immunosuppressive TME characterized by increased M2 macrophages and reduced antitumor CD4+ T and NK cells [106, 107, 108, 109]. The gene discussed is DKK1; the disease is neoplasm.